The addition of obinutuzumab to standard care increased the complete renal response rate by 13.4 percentage points in patients with active proliferative lupus nephritis. At week 76, a significantly ...

One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure. Voclosporin, a novel calcineurin inhibitor, is effective in patients with severe lupus nephritis ...

Lupus nephritis is one of the most serious complications of systemic lupus erythematosus (SLE). It occurs when the immune system mistakenly attacks the kidneys, leading to inflammation and possibly to ...

A combination therapy for lupus nephritis resulted in higher rates of complete remission at 24 months compared with cyclophosphamide treatment, according to an open-label, multicenter, randomized ...

This transcript has been edited for clarity. Matthew A. Sparks, MD: I'm Dr Matthew Sparks, and welcome to Medscape's InDiscussion podcast series on chronic kidney disease. Today we'll be discussing ...

The American College of Rheumatology last published recommendations for managing lupus nephritis (LN) in 2012. Since then, targeted treatments including belimumab (Benlysta) and voclosporin (Lupkynis) ...

Lupkynis is a medicine that is used for a specific kidney disease called lupus nephritis. Lupus nephritis is a kidney condition that affects people with systemic lupus erythematosus (SLE). SLE is an ...

Inflammation from lupus can cause a type of kidney disease called lupus nephritis. Learn more about how lupus affects the kidneys and lupus nephritis. For some people, lupus nephritis can lead to ...

When added to standard care, more lupus nephritis patients achieved complete remissions with obinutuzumab (Gazyva) than with placebo. Treatment was added to mycophenolate mofetil and glucocorticoids.

Please provide your email address to receive an email when new articles are posted on . The FDA has approved obinutuzumab for the treatment of adults with active lupus nephritis who are receiving ...

The total lupus nephritis market size is anticipated to experience growth during the forecast period due to the rising prevalence of lupus nephritis, increasing awareness and adoption of approved ...